Announced Fri, 24 Oct · 16:19 IST

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve Board Meeting of the Company ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sunil Healthcare Ltd has informed BSE that its 265th Board Meeting is scheduled for Tuesday, November 4, 2025, via video conferencing. The board will, among other things, consider and approve the unaudited financial results (both standalone and consolidated) for the second quarter and first half of FY 2025-26, ended September 30, 2025. The company has also confirmed that the trading window for insiders remains closed from October 1, 2025 to November 6, 2025 (both days inclusive). No specific financial numbers, projections, or decisions have been disclosed in this intimation.

Likely market impact

This is a routine regulatory intimation ahead of the Q2/H1 FY26 results announcement. Investors should watch for the actual results release on or after November 4, 2025, which could move the stock depending on the numbers. The closed trading window signals that insiders are restricted from trading until results are publicly available.